Login / Signup

ORI monitoring allows a reduction of time with hyperoxia in critically ill patients: the randomized control ORI2 study.

Sigismond LasockiAntoine BrochantMaxime LegerThomas GaillardPierre LemariéSoizic GergaudPauline Dupré
Published in: Intensive care medicine (2019)
Keyphrases
  • double blind
  • open label
  • placebo controlled
  • clinical trial